Physician profile
Vu Nguyen
NPI 1104189695
$145,012.78
in general payments reported to CMS, 2019-2025
11 companies · $64K in 2025
The $64K reported for 2025 was more than what 98% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2022: $17K · 2023: $22K · 2024: $42K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112K · Travel and Lodging: $13K · Food and Beverage: $3,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111,754.36 |
| Travel and Lodging | $12,822.21 |
| Food and Beverage | $3,711.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $92,764.86 | 2022-2025 | |
| Janssen Biotech, INC. | $44,025.06 | 2024-2025 | Tremfya, Stelara |
| E.R. Squibb & Sons, L.L.C. | $6,590.00 | 2022 | |
| Celgene Corporation | $1,037.01 | 2022-2024 | Zeposia |
| Pfizer INC. | $235.33 | 2023-2025 | |
| Contego Medical, INC | $121.63 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $93.59 | 2019-2025 | Entyvio |
| Portola Pharmaceuticals, LLC | $84.57 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.78 | 2024 | Xifaxan |
| Exact Sciences Corporation | $20.38 | 2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $19.57 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vu Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.